Improving secondary prevention in fragility fracture patients: The impact of a simple clinical information procedure

Journal of Applied Research

Volumn 4, Issue 4, 2004, Pages 570-575

  Schmid, Lukas ^a   Henzen, Christoph ^b   Schlumpf, Urs ^a   Babst, Reto ^c  

^a Division of Rheumatology   (Switzerland)

^b Division of Endocrinology   (Switzerland)

^c Surgical Clinic A   (Switzerland)

Author keywords

Fracture clinic intervention; Fragility fractures; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPRESSION OSTEOSYNTHESIS; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HORMONE SUBSTITUTION; HUMAN; INFORMATION DISSEMINATION; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PATIENT INFORMATION; PROSPECTIVE STUDY;

EID: 11844294998     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cooper C. The crippling consequences of fractures and their impact on quality of life. Am J Med. 1997;103:12S-17S.
2. Gold TD. The nonskeletal consequences of osteoporotic fractures. Psychologic and social outcomes. Rheum Dis Clin North Am. 2001;27:255-262.
3. Jalava T, Sarna S, Pylkkänen L, et al. Association between fracture and increased mortality in osteoporotic patients. Osteoporos Int. 2003;11:556-561.
4. Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D. Risk of mortality following clinical fractures. Osteoporos Int. 2000;11:556-561.
5. Minne HW, Pfeifer M. Evidenzbasierte Ttherapie der osteoporose. Dtsch Med Wochenschr. 2003;128:931-924.
6. Lippuner K, Overbeck J, Perrelet R, Bosshard H, Jaeger Ph. Incidence and direct medical costs of hospitalization due to osteoporotic fractures in Switzerland. Osteoporos Int. 1997;7:414-425.
7. Black DM, Arden NK, Palermo L, et al. for the Study of Osteoporotic Fractures Research Group. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. J Bone Miner Res. 1999;14:821-827.
8. Melton III LJ, Atkinson EJ, Cooper C, O'Fallon WM, Riggs BL. Vertebral fractures predict subsequent fractures. Osteoporos Int. 1999;10:214-221.
9. Chapurlat RD, Bauer DC, Nevitt M, Stone K, Cummings SR. Incidence and risk factors for a second hip fracture in elderly women. The study of osteoporotic fractures. Osteoporos Int. 2003;14:130-136.
10. Robinson CM, Royds M, Abraham A, Mc Quen MM, Court CM, Christie J. Refractures in patients at least forty-five years old. J Bone Joint Surg. 2002;84:1528-1534.
11. Klotzbuecher C, Ross PD, Landsman PB, Abbott TA III, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721-739.
12. Andrade SE, Majumdar SR, Chan A, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med. 2003;163:2052-2057.
13. Johnell O, Kannus P, Obrant KJ, Järvinen M, Parkkari J. Management of the patient after an osteoporotic fracture. Acta Orthop Scand. 2001;72:325-330.
14. Freedman K, Kaplan FS, Bilker WB, Strom BL, Lowe RA. Treatment of osteoporosis: Are physicians missing an opportunity? J Bone Joint Surg. 2000;82:1063-1070.
15. Castel H, Bonneh DY, Sherf M, Liel Y. Awareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low-impact fractures. Osteoporos Int. 2001;12:559-564.
16. Kamel HK, Hussain MS, Tariq S, Perry HM III, Morley JE. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med. 2000;109:326-328.
17. Jachna CM, Whittle J, Lukert B, Graves L, Bhargava T. Effect of hospitalist consultation on treatment of osteoporosis in hip fracture patients. Osteoporos Int. 2003;14:665-671.
18. Juby AG, De Geus CM. Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int. 2002;11:556-561.
19. Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J. Underuse of osteoporosis medications in elderly patients with fractures. Am J Med. 2003;115:398-400.
20. Black DM, Cummings SR, Karpf DB, et. al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348:1535-1541.
21. Pols HA, Felsenberg D, Hanley DA, et al. Multinational, placebo-controlled randomized trial of the effects of alendronate on bone density and fracture risk in post-menopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int. 1999;9:461-468.
22. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA. 1999;282:1344-1352.
23. Melton LJ, Thamer M, Ray NF, et al. Fractures attributable to osteoporosis: Report from the National Osteoporosis Foundation. J Bone Miner Res. 1997;12:16-22.
24. Ross PhD, Davis JW, Epstein RS, et al. Preexisting fractures and bone mass predict vertebral fracture incidence in women. Ann Int Med. 1991;114:919-923.
25. Schutz M, Sudkamp NP. Revolution in plate osteosynthesis: new internal fixator systems. J Orthop Sci. 2003;8:252-258.
26. Gardner MJ, Flik KR, Pekka Mooar, Lane JM. Improvement in the undertreatment of osteoporosis following hip fracture. J Bone Joint Surg. 2002;84:1342-1348.
27. Toulotte C, Fahre C, Dangremont B, Lensel G, Thévenon A. Effects of physical training on the physical capacity of frail, demented patients with a history of falling: a randomised controlled trail. Age Ageing. 2003;32:67-73.
28. Staeger P, Burnand B, Santos B, et al. Prevention of recurrent hip fracture. Aging Clin Exp Res. 2000;12:13-21.
29. Hawker G, Ridout R, Ricupero M, Jaglal S. The impact of a simple fracture clinic intervention in improving the diagnosis and treatment of osteoporosis in fragility fracture patients.
30. Chevalley T, Hoffmeyer P, Bonjour JP, Rizzoli R. An osteoporosis clinical pathway for the medical management of patients with low trauma fracture. Osteoporos Int. 2002;13:450-455.